EntryPoint Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
EntryPoint Capital's EW Position: Q2 2026 in Review
EntryPoint Capital held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,761 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #615.
EntryPoint Capital first reported a position in EW in Q4 2023 and has held it in 6 quarters since. The position peaked at $686K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- EntryPoint Capital held 2,761 shares of Edwards Lifesciences worth $250K as of Q2 2026.
- EntryPoint Capital left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.06% of EntryPoint Capital's portfolio in Q2 2026, its #615 holding.
- EntryPoint Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 6 quarters since.
- EntryPoint Capital's Edwards Lifesciences position peaked at $686K in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.